Osteoclast-rich osteosarcoma.

Area of Science:

• Oncology
• Orthopedic Pathology
• Radiology

Background:

• Osteosarcoma is a primary malignant bone tumor.
• Osteoclast-rich osteosarcoma (OROS) is a rare subtype characterized by numerous osteoclasts and minimal tumor osteoid.
• OROS accounts for approximately 3% of all primary osteosarcomas.

Purpose of the Study:

• To describe the clinicopathological and radiological features of nine cases of primary osteoclast-rich osteosarcoma.
• To differentiate OROS from other bone lesions, including benign conditions and telangiectatic osteosarcoma.
• To enhance understanding of this rare osteosarcoma variant.

Main Methods:

• Retrospective analysis of nine cases diagnosed with primary osteoclast-rich osteosarcoma.
• Histopathological review focusing on cellular composition (osteoclasts, tumor cells) and osteoid production.
• Radiological assessment of lesion characteristics, including margins, bone destruction, and periosteal reaction.

Main Results:

• Nine cases of OROS were identified, representing about 3% of primary osteosarcomas.
• Histologically, these tumors show an abundance of osteoclasts and a scarcity of tumor osteoid.
• Radiological features are often atypical for osteosarcoma, presenting as ill-defined, predominantly lytic lesions in the diaphysis or metaphysis of long bones, with scanty periosteal reaction and no significant soft-tissue mass.

Conclusions:

• Osteoclast-rich osteosarcoma is a distinct entity that can be challenging to diagnose radiologically.
• Its histological features suggest a relationship with telangiectatic osteosarcoma, possibly representing a solid variant.
• Awareness of OROS's unique presentation is crucial for accurate diagnosis and appropriate patient management.